Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection

被引:0
|
作者
Qi Zhang [1 ]
Hai-Feng Xu [2 ]
Wen-Yue Song [1 ]
Peng-Jun Zhang [2 ]
Yong-Bo Song [1 ]
机构
[1] School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University
[2] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Interventional Therapy Department, Peking University Cancer Hospital and Institute
基金
国家重点研发计划;
关键词
Hepatitis B virus infection; Hepatocellular carcinoma; MicroRNAs; Cirrhosis; Biomarker; Tissue;
D O I
暂无
中图分类号
R735.7 [肝肿瘤]; R512.62 [];
学科分类号
100214 ; 100401 ;
摘要
BACKGROUND In hepatocellular carcinoma(HCC), abnormal expression of multiple micro RNAs(miRNAs) has been shown to be involved in the malignant biological behavior of liver cancer. The vast majority of liver cancer cases in China are closely related to hepatitis B virus(HBV) infection, but there are few studies on the changes of miRNA expression in the progression from HBV infection to hepatoma.AIM To explore the role of miRNAs in the progression of HBV infection to cirrhosis and even to liver cancer.METHODS We screened differentially expressed miRNAs in 40 HBV cirrhosis, 40 normal and15 HCC tissues by using a Taq Man Low Density Array and real time quantitative polymerase chain reaction. To evaluate the power of the selected miRNAs to predict disease, we calculated the area under the receiver-operating-characteristic curves. The overall survival of HBV cirrhosis patients was analyzed via KaplanMeier analysis.RESULTS The levels of miR-375, miR-122 and miR-143 were significantly lower in HBV cirrhosis tissues, while miR-224 was significantly higher than in the controls(P <0.0001). The area under the curves of the receiver-operating-characteristic curve for the 4-miRNA panel was 0.991(95%CI: 0.974-1). Patients with a lower expression level of miR-224 or higher expression levels of miR-375, miR-122 and miR-143 had longer overall survival.CONCLUSIONThe four miRNAs(miR-375, miR-122, miR-143 and miR-224) may be helpful for early diagnosis of HBV infection, HBV cirrhosis, and prediction of its overall survival.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 50 条
  • [41] Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ONCOLOGY, 2011, 81 : 41 - 49
  • [42] Surveillance for hepatocellular carcinoma in chronic hepatitis B virus infection: for whom
    Jihyun An
    Lee, Han Chu
    HEPATIC ONCOLOGY, 2015, 2 (03) : 225 - 229
  • [43] Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
    Zhang, Yaqin
    Cao, Weihua
    Wang, Shiyu
    Zhang, Lu
    Li, Xinxin
    Zhang, Ziyu
    Xie, Yao
    Li, Minghui
    VIRULENCE, 2024, 15 (01)
  • [44] Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
    Li, Xiaofei
    Sheng, Lina
    Liu, Liwen
    Hu, Yongtao
    Chen, Yongxin
    Lou, Lianqing
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [45] Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
    Mengchao An
    Wenkang Wang
    Jie Zhang
    Brian G. Till
    Lingdi Zhao
    Hao Huang
    Yonghao Yang
    Tiepeng Li
    Lu Han
    Xiaojie Zhang
    Peng Qin
    Yunjian Wang
    Min Zhang
    Hong Cui
    Quanli Gao
    Zibing Wang
    Cancer Immunology, Immunotherapy, 2023, 72 : 385 - 395
  • [46] Hepatitis B virus and hepatocellular carcinoma at the miRNA level
    Zhang, Zhen-Zhen
    Liu, Xiang
    Wang, De-Qiang
    Teng, Mai-Kun
    Niu, Li-Wen
    Huang, Ai-Long
    Liang, Zhi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (28) : 3353 - 3358
  • [47] Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Xie, Youhua
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 11 - 21
  • [48] microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma
    Fujun Yu
    Zhongqiu Lu
    Bicheng Chen
    Peihong Dong
    Jianjian Zheng
    Diagnostic Pathology, 10
  • [49] Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
    Zhang, Ying
    Li, Tao
    Qiu, Yumin
    Zhang, Tao
    Guo, Pengbo
    Ma, Xiaomin
    Wei, Qing
    Han, Lihui
    MEDICINE, 2017, 96 (02)
  • [50] Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Chen, Yueming
    Dong, Xueyan
    Yu, Daojun
    Wang, Xianjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18462 - 18468